Editorials

Personalized Psychiatry: why?

Date: 1 January 2015
Author: Giampaolo Perna
Comments: 0 Comments
Categories: Editorials

In psychiatric disorders, treatment-resistant patients represent high medical costs for management of clinical condition. Studies in literature report high percentage of patients with a treatment resistance. In schizophrenia this percentage is counted to be 20 to 50% [1], whereas in bipolar disorder the resistance occurs in 40% of patients after…

Personalized Psychiatry: Why Science matters…

Date: 19 December 2014
Author: Giampaolo Perna
Comments: 0 Comments
Categories: Editorials

While organizing the WPA section on Personalized Psychiatry some reflections come to my mind. In our daily clinical activity we think like personalized psychiatrists, and even in more general, we think in a personalized way. We have several experiences in a field, we see, for example, many patients, we read…

prof. Bernard Lerer

Prof. Charles Nemeroff

Prof. Stephen Koslow

prof. Bernard Lerer

Professor Bernard Lerer gives this lecture entitled Pharmacogenetics of Antipsychotic Drug Treatment: From Man to Mouse to Clinical Diagnosis' at The Australian National University on 17 August 2010. This Public Lecture was held in conjunction with The Bootes Course on Translational Medicine: The Pathway from Discovery to Healthcare at the University's John Curtin School of Medical Research.

View More
Prof. Charles Nemeroff

"Personalized Medicine in Psychiatry" presented by Charles B. Nemeroff, MD, PhD, on October 5, 2012, as part of the Dorothy C. Fuqua Lecture Series "Trailblazing in Psychiatry: Charting future paths of mental health treatments" organized and hosted by Skyland Trail.

View More
Prof. Stephen Koslow

Professor Stephen Koslow gives this presentation at the First National Symposium on Translational Psychiatry, 4 -5 April 2011, at The John Curtin School of Medical Research, The Australian National University. Dr. Stephen H. Koslow, PhD has been an innovator and creative leader in the fields of psychopharmacology, neuroscience and informatics. He continues to run his own consulting company, and his efforts in Neuroinformatics, and special interest in the clinical areas of mental illness. He had worked for many years at the National Institutes of Mental Health (NIH) where he had a major leadership role in these same areas.

View More

html{margin-top:35px}"Questo sito si avvale di cookie necessari al funzionamento ed utili alle finalit\u00e0 illustrate nella cookie policy. Se vuoi saperne di pi\u00f9 consulta la cookie policy. Chiudendo questo banner, cliccando su un link o proseguendo la navigazione in altra maniera, acconsenti all\u2019uso dei cookie."COOKIE POLICY